Moreover, we also compared gastric cancer stem cells marker expression, such as OCT-4, Sox2, Nanog, Survivin and CD44, in tumor spheres and tumor spheres treated with ICG-001, which showed those markers were higher in tumor spheres than cell lines, but declined after ICG-001 treatment (Fig. 2c and d). This evidence concerns the gene SOX2 and gastric cancer.